← Home / ImageneBio, Inc. (IMA)
Stock Analysis
ImageneBio, Inc. (IMA)
IMA
IMA · Market data
5.91 +0.17%
52W Range Position
10%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-12 19:53 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 6.55. Holding above 5.81 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Insufficient
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
5.81
↗
Break Above
Confirmation improves above resistance.
6.55
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 5.81
What's Driving IMA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 6.55 for confirmation and 5.81 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 5.85 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression
State
Forming
Compression
35%
RSI(14)
52.6
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 5.85 and resistance around 7.40. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
IMA · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-09
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$66.1M
Company size
EV
$-9.9M
Debt-adjusted value
P/E
-1.4
Not meaningful
P/S
82.7
Very high
P/B
0.5
Low book multiple
EV/Sales
-12.4
Not meaningful
EV/EBIT
0.2
Low multiple
P/FCF
-1.3
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Insufficient
≈
Cash Flow
Positive
⚖
Balance Sheet
Strong
💵 Revenue
0.00
↘ Weak
📈 Net Income
-10.62M
≈ Insufficient
🧮 EPS (Basic)
-0.95
≈ Insufficient
ImageneBio, Inc.
Related Opportunities